Utility of preoperative 18F-FDG PET/CT and brain MRI in Melanoma patients with palpable Lymph node metastases

Annals of Surgical Oncology

Volumn 17, Issue 10, 2010, Pages 2773-2778

  Aukema, Tjeerd S ^a   Valdés Olmos, Renato A ^a   Wouters, Michel W J M ^a   Klop, W Martin C ^a   Kroon, Bin B R ^a   Vogel, Wouter V ^a   Nieweg, Omgo E ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FLUORODEOXYGLUCOSE F 18; TEMOZOLOMIDE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEUROIMAGING; OVERALL SURVIVAL; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; SENSITIVITY AND SPECIFICITY; STANDARD;

AGED; BRAIN NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 78049465014     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1088-y     Document Type: Article

References (28)

1. CM Balch SJ Soong JE Gershenwald JF Thompson DS Reintgen N Cascinelli, et al. 2001 Prognostic factors analysis of 17, 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol. 19 3622 3634 1:STN:280:DC%2BD3MvlvV2ktA%3D%3D 11504744
2. TM Hughes RP A'Hern JM Thomas 2000 Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma Br J Surg. 87 892 901 1:STN:280:DC%2BD3cvgtFymtw%3D%3D 10.1046/j.1365-2168.2000.01439.x 10931025
3. DS Reintgen C Cox CL Slingluff Jr HF Seigler 1992 Recurrent malignant melanoma: the identification of prognostic factors to predict survival Ann Plast Surg. 28 45 49 1:STN:280:DyaK38zlt1WnsA%3D%3D 10.1097/00000637-199201000-00013 1642405
4. SJ Soong RA Harrison WH McCarthy MM Urist CM Balch 1998 Factors affecting survival following local, regional, or distant recurrence from localized melanoma J Surg Oncol. 67 228 233 1:STN:280:DyaK1c3jvV2ksA%3D%3D 10.1002/(SICI)1096-9098(199804)67:4<228::AID-JSO4>3.0.CO;2-A 9579369
5. GS Mijnhout OS Hoekstra MW van Tulder GJ Teule WL Deville 2001 Systematic review of the diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography in melanoma patients Cancer. 91 1530 1542 1:STN:280: DC%2BD3M3mtFCrtQ%3D%3D 10.1002/1097-0142(20010415)91:8<1530::AID- CNCR1162>3.0.CO;2-# 11301402
6. AM Fink S Holle-Robatsch N Herzog S Mirzaei K Rappersberger N Lilgenau, et al. 2004 Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II Melanoma Res. 14 141 145 10.1097/00008390-200404000-00011 15057045
7. JD Wagner D Schauwecker D Davidson T Logan JJ Coleman III G Hutchins, et al. 2005 Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma Cancer. 104 570 579 10.1002/cncr.21189 15977211
8. KP Friedman RL Wahl 2004 Clinical use of positron emission tomography in the management of cutaneous melanoma Semin Nucl Med. 34 242 253 10.1053/j.semnuclmed.2004.06.001 15493002
9. IA Ho Shon DK Chung RP Saw JF Thompson 2008 Guidelines for imaging in cutaneous melanoma Nucl Med Commun. 29 877 879 10.1097/MNM.0b013e3283043a0c 18769304
10. G Antoch N Saoudi H Kuehl G Dahmen SP Mueller T Beyer, et al. 2004 Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET J Clin Oncol. 22 4357 4368 10.1200/JCO.2004.08.120 15514377
11. E Pelosi C Messa S Sironi M Picchio C Landoni V Bettinardi, et al. 2004 Value of integrated PET/CT for lesion localisation in cancer patients: a comparative study Eur J Nucl Med Mol Imaging. 31 932 939 10.1007/s00259-004- 1483-3 14991245
12. MJ Reinhardt AY Joe U Jaeger A Huber A Matthies J Bucerius, et al. 2006 Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients J Clin Oncol. 24 1178 1187 10.1200/JCO.2005.03.5634 16505438
13. B Krug R Crott M Lonneux JF Baurain AS Pirson T Vander Borght 2008 Role of PET in the initial staging of cutaneous malignant melanoma: systematic review Radiology. 249 836 844 10.1148/radiol.2493080240 19011184
14. K Kitajima Y Nakamoto H Okizuka Y Onishi M Senda N Suganuma, et al. 2008 Accuracy of whole-body FDG-PET/CT for detecting brain metastases from non-central nervous system tumors Ann Nucl Med. 22 595 602 10.1007/s12149-008- 0145-0 18756362
15. EM Rohren JM Provenzale DP Barboriak RE Coleman 2003 Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy Radiology. 226 181 187 10.1148/radiol.2261010920 12511688
16. E Bastiaannet WJ Oyen S Meijer OS Hoekstra T Wobbes PL Jager, et al. 2006 Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients Br J Surg. 93 243 249 1:STN:280: DC%2BD28%2FmsVWiug%3D%3D 10.1002/bjs.5174 16323165
17. MS Brady T Akhurst K Spanknebel S Hilton M Gonen A Patel, et al. 2006 Utility of preoperative [18F] fluorodeoxyglucose-positron emission tomography scanning in high-risk melanoma patients Ann Surg Oncol. 13 525 532 10.1245/ASO.2006.02.008 16474909
18. SA Gulec MB Faries CC Lee D Kirgan C Glass DL Morton, et al. 2003 The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making Clin Nucl Med. 28 961 965 10.1097/01.rlu.0000099805.36471.aa 14663316
19. J Horn J Lock-Andersen H Sjostrand A Loft 2006 Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy Eur J Nucl Med Mol Imaging. 33 887 892 10.1007/s00259-006-0077-7 16586078
20. E Bastiaannet T Wobbes OS Hoekstra EJ van der Jagt AH Brouwers R Koelemij, et al. 2009 Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: Diagnostic accuracy and impact on treatment J Clin Oncol. 27 4774 4780 10.1200/JCO.2008.20.1822 19720925
21. C Pfannenberg P Aschoff S Schanz SM Eschmann C Plathow TK Eigentler, et al. 2007 Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma Eur J Cancer. 43 557 564 10.1016/j.ejca.2006.11.014 17224266
22. MS Falk AK Truitt FV Coakley M Kashani-Sabet RA Hawkins B Franc 2007 Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma Nucl Med Commun. 28 273 280 1:CAS:528:DC%2BD2sXitFyltb4%3D 10.1097/MNM.0b013e3280708ecf 17325590
23. B Singh S Ezziddin H Palmedo M Reinhardt H Strunk T Tüting, et al. 2008 Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma Melanoma Res. 18 346 352 10.1097/CMR.0b013e32830b363b 18781133
24. P Veit-Haibach FM Vogt R Jablonka H Kuehl A Bockisch T Beyer, et al. 2009 Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma Eur J Nucl Med Mol Imaging. 36 910 918 10.1007/s00259-008-1049-x 19156409
25. K Strobel R Dummer DB Husarik M Perez Lago TF Hany, et al. 2007 High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases Radiology. 244 566 574 10.1148/radiol.2442061099 17641374
26. PB Clark V Soo J Kraas P Shen EA Levine 2006 Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma Arch Surg. 141 284 288 10.1001/archsurg.141.3. 284 16549694
27. F Crippa M Leutner F Belli F Gallino M Greco S Pilotti, et al. 2000 Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma J Nucl Med. 41 1491 1494 1:STN:280:DC%2BD3cvksVenuw%3D%3D 10994727
28. PD Schellinger HM Meinck A Thron 1999 Diagnostic accuracy of MRI compared to CCT in patients with brain metastases J Neurooncol. 44 275 281 1:STN:280:DC%2BD3c7otlWnuw%3D%3D 10.1023/A:1006308808769 10720207